Method of treatment of retinal ischemia with diazoxide
US8063054B2 · kind B2 · utility
3Cited by
0References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 7, 2005 |
| Grant date | Nov 22, 2011 |
| Priority date | — |
| Expiry date | Jul 30, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition including diazoxide (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine-1,1-dioxide) for the treatment and/or prevention of retinal ischemia and of diseases associated with retinal ischemia. The composition can also contain riluzole, a derivative active in neuroprotection of the latter, or a pharmaceutically acceptable salt of the latter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.